Blue Apron provides recipes, ingredients, and cooking techniques. The company's products include: meals, which consist of a Two-Serving Plan that serves two people, and a Family Plan that serves four people; wine, through Blue Apron Wine delivery service to deliver wines, including red and white wines (and roses, depending on the season), tasting notes, pairing tips, and the story behind each wine; market, which features a selection of cooking tools, utensils, and pantry items through its e-commerce marketplace, Blue Apron Market; and digital experience, which provides how-to cooking videos, stories about its suppliers, and its collection of various recipes that customers can access on their own.

Cassava Sciences is a clinical-stage drug development company. The company focuses on developing new product candidates and to guide these through various regulatory and development pathways in preparation for their potential commercialization. The company's clinical-stage biopharmaceutical assets include: PTI-125, which is its product candidate for the treatment of Alzheimer's disease; and PTI-125Dx, which it is developing as a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company owns worldwide rights to PTI-125 and PTI-125Dx, without royalty obligations to any third party.

Core Molding Technologies operates in the composites market in a family of products known as structural composites. Structural composites are combinations of resins and reinforcing fibers (typically glass or carbon) that are molded to shape. The company is a manufacturer of sheet molding compound (SMC) and molder of thermoset and thermoplastic products. The company focuses on moldings and provides processes, including compression molding of SMC, glass mat thermoplastics, bulk molding compounds and direct long fiber thermoplastic, spray-up, hand-lay-up, resin transfer molding, structural foam and structural web injection molding, and reaction injection molding, utilizing dicyclopentadiene technology.

Highwoods Properties is a real estate investment trust. The company owns, develops, acquires, leases and manages properties primarily in the business districts of Atlanta, Charlotte, Nashville, Orlando, Pittsburgh, Raleigh, Richmond and Tampa. The company's primary business is the operation, acquisition and development of office properties. The company conducts its activities through its subsidiary, Highwoods Realty Limited Partnership. The company provides a line of real estate services to its customers. The company provides its customers with services such as build-to-suit construction and space modification, including tenant improvements and expansions.

Net 1 UEPS Technologies provides financial technology, products and services. The company has developed and owns most of its payment technologies, and where possible, utilizes this technology to provide financial and services to its customers by including them into the formal financial system. The company's primary payment technology is called the Universal Electronic Payment System (UEPS), and its EMV interoperable derivative, UEPS/EMV, utilizes a form of distributed ledger technology, providing decentralized and biometrically secure smart cards that operate in real-time but both off-line and on-line. The company's financial inclusion products and services are delivered through its UEPS-based core banking system.

Stellus Capital Investment is an externally managed, closed-end, non-diversified management investment company. The company's investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments in middle-market companies.